
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals Limited
Filed with BSE · · 1 page · English

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Ltd on 6ix
Follow Kwality Pharmaceuticals into a list and get an email when it puts out news.
Follow Kwality Pharmaceuticals